Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3376405 | Journal of Infection | 2006 | 10 Pages |
Abstract
As judged from effects on circulating IGF-I, glucose metabolism, and insulin kinetics, 0.7Â mg/day of GH may be expedient for treatment of HIV-infected males with lipodystrophy. Whether the patients' glucose metabolic status matters for the IGF-response to low-dose GH-therapy awaits further investigation.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Steen B. Haugaard, Ove Andersen, Allan Flyvbjerg, Hans Ãrskov, Sten Madsbad, Johan Iversen,